40 results
424B5
CRVS
Corvus Pharmaceuticals, Inc.
3 May 24
Prospectus supplement for primary offering
4:05pm
that contained in or incorporated by reference in this prospectus supplement and the accompanying prospectus. We take no responsibility for, and can provide … supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can
8-K
EX-99.1
bamqm 9igh9h52wruy
19 Mar 24
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:02pm
8-K
EX-1.1
s0vg5l be
2 Nov 21
Entry into a Material Definitive Agreement
6:10am
424B5
im7sy4nmbp364 gp
2 Nov 21
Prospectus supplement for primary offering
6:05am
424B5
xhl5wch4r0h4k48pn0
12 Feb 21
Prospectus supplement for primary offering
9:00am
424B5
peir8c53p8k
11 Feb 21
Prospectus supplement for primary offering
5:14pm
8-K
EX-2.1
mu50amw0pi0o17s5 oe
5 Oct 20
Entry into a Material Definitive Agreement
4:50pm